Efficacy of zinc supplementation for the treatment of dysmenorrhoea: a double-blind randomised controlled trial.

Hillary I ObiagwuGeorge Uchenna ElejeNworah J A ObiechinaBetrand O NwosuGerald O UdigweJoseph I IkechebeluJoseph O UgboajaChukwuemeka C OkoroIfeanyi O OkonkwoAyodele O OkwuosaCharlotte B OguejioforChisom G ChigboChukwudi A OgabidoChidinma Charity OkaforChigozie Geoffrey Okafor

Published in: The Journal of international medical research (2023)

Zinc sulfate reduces dysmenorrhoea severity with minimal or no adverse effects, especially with more than one cycle of usage.Trial Registration Number: PACTR202105843292338. The trial is publicly available and was registered at www.pactr.org on 25 May 2021.

Keyphrases

study protocol
phase iii
clinical trial
phase ii
randomized controlled trial
oxide nanoparticles
open label
combination therapy
replacement therapy